BioRestorative Therapies, Inc. Common Stock (NV)
Symbol: BRTX (NASDAQ)
Company Description:
BioRestorative Therapies Inc is a biotechnology company based in the United States. It focuses on the development of regenerative medicine products and therapies using cell and tissue protocols, involving adult (non-embryonic) stem cells. The company's two core development programs include the Disc/Spine Program, which involves cell therapy candidate, BRTX-100, a product formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow; and the Metabolic Program, which includes the development of cell-based therapy to target obesity and metabolic disorders using brown adipose-derived stem cells, to generate brown adipose tissue.
- Today's Open: $1.3855
- Today's High: $1.464
- Today's Low: $1.351
- Today's Volume: 14.36K
- Yesterday Close: $1.45
- Yesterday High: $1.46
- Yesterday Low: $1.395
- Yesterday Volume: 43.02K
- Last Min Volume: 34
- Last Min High: $1.45
- Last Min Low: $1.45
- Last Min VWAP: $1.45
- Name: BioRestorative Therapies, Inc. Common Stock (NV)
- Website: https://www.biorestorative.com
- Listed Date: 1997-12-22
- Location: MELVILLE, NY
- Market Status: Active
- CIK Number: 0001505497
- SIC Code: 8090
- SIC description: SERVICES-MISC HEALTH & ALLIED SERVICES, NEC
- Market Cap: $11.57M
- Round Lot: 100
- Outstanding Shares: 7.98M
- Asset Type: CS
Filing Date | Filing Type | Format |
---|---|---|
2025-09-25 | 8-K | View |
2025-08-14 | 8-K | View |
2025-08-14 | SCHEDULE 13G/A | View |
2025-08-12 | 10-Q | View |
2025-08-12 | 8-K | View |
2025-08-08 | DEF 14A | View |
2025-06-13 | 8-K | View |
2025-05-15 | SCHEDULE 13G/A | View |
2025-05-14 | 10-Q | View |
2025-05-14 | 8-K | View |
2025-04-21 | 8-K | View |
2025-03-28 | 10-K | View |
2025-03-27 | 8-K | View |
2025-02-28 | SCHEDULE 13G/A | View |
2025-02-19 | SCHEDULE 13D/A | View |
2025-02-19 | SCHEDULE 13D/A | View |
2025-02-19 | 4 | View |
2025-02-19 | 4 | View |
2025-02-19 | 4 | View |
2025-02-19 | 4 | View |